#USA #Chicago #Neusoft Medical #photon-counting CT #NeuViz P10

Neusoft Medical Unveils Groundbreaking Imaging Innovations at RSNA 2025

Neusoft Medical Systems Co., Ltd. has made significant strides in medical imaging technologies at the Radiological Society of North America (RSNA) Annual Meeting 2025, held in Chicago. The company proudly reveals its flagship innovation – the NeuViz P10, the world's first photon-counting CT scanner with an impressive 8cm wide coverage. This state-of-the-art technology is a game-changer in the field of medical imaging, and it reflects Neusoft's commitment to advancing healthcare solutions globally.

Zhang Dan, Vice President and General Manager of Neusoft Medical's International Business Center, expressed pride in presenting these cutting-edge technologies. He highlighted how these innovations stem from a deep understanding of user needs and the company’s dedication to enhancing workflow efficiency and diagnostic accuracy.

Key Innovations at the Exhibition

Apart from the NeuViz P10, several other high-end imaging systems were showcased, embodying the vision of a fully integrated intelligent healthcare ecosystem. This ecosystem facilitates seamless transitions from screening to diagnosis, treatment, rehabilitation, and research. The key products featured included:

1. NeuViz P10 Photon-Counting CT

This innovative CT scanner utilizes cadmium zinc telluride (CZT) semiconductor detectors, offering exceptional spatial resolution of 50 lp/cm while significantly reducing radiation doses. Its advanced capabilities allow for precise multi-energy imaging, enabling superior tissue characterization, which is crucial for accurate diagnoses.

2. NeuViz Spire Max+ CT

This high-end system incorporates liquid metal bearing technology to manage large heat capacities and facilitate low-dose scanning at 70 kV. Like the P10, it’s supported by an integrated NeuAI platform aimed at enhancing operational workflows within medical facilities, promising efficiency improvements for healthcare practitioners.

3. NeuMR 3.0T

As China's first comprehensive molecular research MRI, the NeuMR 3.0T represents a leap forward in molecular metabolic imaging. Leveraging both innovative hardware and AI-driven reconstruction methods, this device is set to advance precision medicine research significantly and help medical professionals better understand complex diseases.

4. NeuAngio-CT

This multi-modality intervention solution offers streamlined pathways for diagnosing and treating critical conditions such as chest pain, stroke, trauma, and oncology. The integrated approach aids medical staff in swift decision-making and enhances patient care timelines.

Global Expansion and Acceptance

Neusoft Medical's latest innovations have not only captivated attention but also gained substantial traction across the globe. The company boasts installations in over 120 countries, with more than 50,000 units deployed worldwide. Their premium systems are particularly popular in developed markets, where notable medical centers across Europe are integrating multiple DSA systems, and CT technologies are being rapidly adopted by both private and university hospitals in Eastern Europe and beyond.

Zhang Dan emphasized the importance of their technological leadership, noting the strong recognition Neusoft Medical has garnered among high-profile clients through the quality of their products and commitment to innovation.

As the healthcare industry continues to evolve, Neusoft Medical is well-positioned to lead the charge in enhancing imaging technologies that contribute significantly to improved clinical outcomes. With the launch of the NeuViz P10 and associated systems, patients and practitioners alike can look forward to a future where diagnostic accuracy and efficiency are markedly improved.

For more information on Neusoft Medical’s groundbreaking innovations, visit Neusoft Medical's official website.